248 related articles for article (PubMed ID: 31739800)
1. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
3. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
6. S100A10 as a novel biomarker in colorectal cancer.
Shang J; Zhang Z; Song W; Zhou B; Zhang Y; Li G; Qiu S
Tumour Biol; 2013 Dec; 34(6):3785-90. PubMed ID: 23828264
[TBL] [Abstract][Full Text] [Related]
7. Multiple functions of S100A10, an important cancer promoter.
Saiki Y; Horii A
Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
[TBL] [Abstract][Full Text] [Related]
8. USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer.
Lei X; Li X; Chen H; Liu Z
Curr Cancer Drug Targets; 2020; 20(9):689-699. PubMed ID: 32359336
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of S100A10 in metastasized breast cancer stem cells.
Yanagi H; Watanabe T; Nishimura T; Hayashi T; Kono S; Tsuchida H; Hirata M; Kijima Y; Takao S; Okada S; Suzuki M; Imaizumi K; Kawada K; Minami H; Gotoh N; Shimono Y
Cancer Sci; 2020 Dec; 111(12):4359-4370. PubMed ID: 32976661
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B
Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
[TBL] [Abstract][Full Text] [Related]
12. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
[TBL] [Abstract][Full Text] [Related]
13. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer.
Christensen MV; Høgdall C; Jensen SG; Lokman N; Ricciardelli C; Christensen IJ; Christiansen P; Brask J; Karlsen MA; Nissen TK; Jochumsen KM; Høgdall E
Anticancer Res; 2019 May; 39(5):2475-2482. PubMed ID: 31092442
[TBL] [Abstract][Full Text] [Related]
14. S100A10 is required for the organization of actin stress fibers and promotion of cell spreading.
Sayeed S; Asano E; Ito S; Ohno K; Hamaguchi M; Senga T
Mol Cell Biochem; 2013 Feb; 374(1-2):105-11. PubMed ID: 23129259
[TBL] [Abstract][Full Text] [Related]
15. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.
Deng M; Sun J; Xie S; Zhen H; Wang Y; Zhong A; Zhang H; Lu R; Guo L
Mol Med Rep; 2019 Sep; 20(3):2258-2266. PubMed ID: 31322224
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2-S100A10 Represents the Regulatory Component of Maxi-Cl Channel Dependent on Protein Tyrosine Dephosphorylation and Intracellular Ca²⁺.
Islam MR; Okada T; Merzlyak PG; Toychiev AH; Ando-Akatsuka Y; Sabirov RZ; Okada Y
Cell Physiol Biochem; 2020 May; 54(4):538-555. PubMed ID: 32442363
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
19. COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer.
Zhou Z; Jin L; Shen J; Shi W; Xu Y; Ye L; Liu J; Pan J
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(1):34-42. PubMed ID: 36647720
[TBL] [Abstract][Full Text] [Related]
20. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
